Cathay Biotech Inc (688065) — Financial Flexibility Index
Cathay Biotech Inc (688065) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥121.64 Million (operating CF CN¥-66.22 Million minus capex CN¥187.86 Million) represents 0% of total liabilities (CN¥2.23 Billion). Check financial resilience of Cathay Biotech Inc to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cathay Biotech Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Cathay Biotech Inc across 9 annual periods. See Cathay Biotech Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cathay Biotech Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Cathay Biotech Inc. For the full company profile including market capitalisation, see market cap of Cathay Biotech Inc.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.42x | CN¥1.66 Billion | CN¥820.93 Million | CN¥3.92 Billion | ▼ -19.4% |
| 2023 | 0.53x | CN¥2.14 Billion | CN¥569.45 Million | CN¥4.06 Billion | ▼ -70.6% |
| 2022 | 1.79x | CN¥5.00 Billion | CN¥803.67 Million | CN¥2.79 Billion | ▲ +31.0% |
| 2021 | 1.37x | CN¥2.07 Billion | CN¥594.18 Million | CN¥1.51 Billion | ▼ -30.3% |
| 2020 | 1.96x | CN¥1.28 Billion | CN¥514.96 Million | CN¥650.74 Million | ▲ +202.2% |
| 2019 | 0.65x | CN¥870.76 Million | CN¥359.62 Million | CN¥1.34 Billion | ▲ +173.5% |
| 2018 | 0.24x | CN¥399.80 Million | CN¥-10.29 Million | CN¥1.68 Billion | ▼ -78.8% |
| 2017 | 1.12x | CN¥1.05 Billion | CN¥53.45 Million | CN¥936.58 Million | ▲ +152.6% |
| 2016 | 0.44x | CN¥194.67 Million | CN¥-128.67 Million | CN¥439.21 Million | — |